Ophthalmology · Concord, NC
NPI
1497748396
Since 2005
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
201 Lephillip Court N.E.
Concord, NC, 28025
Phone (704) 782-1127
Groups this clinician bills Medicare through
Medicare paid, 2024
$237K
2,666 services
Medicare patients, 2024
626
Average age 78
Drug cost, 2024
$618K
9,920 prescriptions
Company payments, 2025
$116
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kurt K Lark was code 99214 (office e&m - established), 739 times for 399 patients. In total Kurt K Lark billed 2,666 services in 36 codes, and Medicare paid $237K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-05-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 739 | 399 | $78.51 | $58K |
| 92083 Vision, Hearing, and Speech Services | Office | 266 | 250 | $40.66 | $11K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 264 | 193 | $10.88 | $2,871 |
| 92133 Computerized Ophthalmic Imaging | Office | 243 | 238 | $23.23 | $5,645 |
| 92136 Ultrasound - Nonspecific | Office | 234 | 147 | $25.90 | $6,062 |
| 66984 Cataract Surgery | Facility | 226 | 135 | $367.69 | $83K |
| 99213 Office E&M - Established | Office | 183 | 172 | $63.67 | $12K |
| 92014 Ophthalmological E&M | Office | 133 | 130 | $77.16 | $10K |
| 99204 Office E&M - New | Office | 65 | 65 | $102.80 | $6,682 |
| 66821 Cataract Surgery | Facility | 57 | 49 | $218.34 | $12K |
| 65855 Fluid Flow and Drainage of Eye (Any Method) | Office | 54 | 34 | $168.32 | $9,089 |
| 92020 Ophthalmological E&M | Office | 48 | 48 | $18.67 | $896 |
| 92250 Angiography | Office | 46 | 46 | $23.33 | $1,073 |
| 92134 Computerized Ophthalmic Imaging | Office | 30 | 26 | $23.42 | $703 |
| 66982 Cataract Surgery | Facility | 17 | 13 | $505.60 | $8,595 |
By year: 2022 $316K for 3,084 services; 2023 $270K for 2,706 services; 2024 $237K for 2,666 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kurt K Lark prescribed most often to Medicare patients was Latanoprost, with 3,035 prescriptions and refills. In total Kurt K Lark wrote 9,920 Medicare prescriptions that cost $618K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 3,035 | 6,028 | 764 | $30K |
| Prednisolone Acetate Generic | 1,295 | 1,810 | 738 | $55K |
| Timolol Maleate Generic | 753 | 1,652 | 232 | $7,312 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 657 | 1,421 | 172 | $11K |
| Ketorolac Tromethamine Generic | 621 | 743 | 333 | $25K |
| Polymyxin B Sul-Trimethoprim Polymyxin B Sulf/Trimethoprim | 590 | 777 | 459 | $5,000 |
| Brimonidine Tartrate Generic | 535 | 953 | 178 | $28K |
| Dorzolamide Hcl Generic | 322 | 694 | 97 | $6,062 |
| Combigan Brimonidine Tartrate/Timolol | 237 | 351 | 51 | $71K |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 221 | 362 | 64 | $33K |
| Moxifloxacin Moxifloxacin Hcl | 173 | 183 | 107 | $4,582 |
| Erythromycin Erythromycin Base | 166 | 177 | 65 | $2,089 |
| Alphagan P Brimonidine Tartrate | 154 | 267 | 45 | $55K |
| Valacyclovir Valacyclovir Hcl | 151 | 228 | 36 | $6,176 |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 146 | 150 | 124 | $1,729 |
Brand drugs: 3,367 claims; generic drugs: 6,553 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kurt K Lark $116 ($116 in general payments such as food, travel and fees) from 3 companies. The largest payer was Abbvie Inc. with $53.54.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.